227 related articles for article (PubMed ID: 30156010)
1. The tumor suppressor BAP1 cooperates with BRAFV600E to promote tumor formation in cutaneous melanoma.
Webster JD; Pham TH; Wu X; Hughes NW; Li Z; Totpal K; Lee HJ; Calses PC; Chaurushiya MS; Stawiski EW; Modrusan Z; Chang MT; Tran C; Lee WP; Chalasani S; Hung J; Sharma N; Chan S; Hotzel K; Talevich E; Shain A; Xu M; Lill J; Dixit VM; Bastian BC; Dey A
Pigment Cell Melanoma Res; 2019 Mar; 32(2):269-279. PubMed ID: 30156010
[TBL] [Abstract][Full Text] [Related]
2. Histomorphologic spectrum of BAP1 negative melanocytic neoplasms in a family with BAP1-associated cancer susceptibility syndrome.
Marušić Z; Buljan M; Busam KJ
J Cutan Pathol; 2015 Jun; 42(6):406-12. PubMed ID: 25902915
[TBL] [Abstract][Full Text] [Related]
3. BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations.
Piris A; Mihm MC; Hoang MP
Hum Pathol; 2015 Feb; 46(2):239-45. PubMed ID: 25479927
[TBL] [Abstract][Full Text] [Related]
4. BAP1-deficient and VE1-negative atypical Spitz tumor.
Requena C; Sanz V; Nagore E; García-Casado Z; Rubio L; Guillén C; Kutzner H
J Cutan Pathol; 2015 Aug; 42(8):564-7. PubMed ID: 25953246
[TBL] [Abstract][Full Text] [Related]
5. BRCA1-associated protein (BAP1)-inactivated melanocytic tumors.
Zhang AJ; Rush PS; Tsao H; Duncan LM
J Cutan Pathol; 2019 Dec; 46(12):965-972. PubMed ID: 31233225
[TBL] [Abstract][Full Text] [Related]
6. A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression.
Wiesner T; Murali R; Fried I; Cerroni L; Busam K; Kutzner H; Bastian BC
Am J Surg Pathol; 2012 Jun; 36(6):818-30. PubMed ID: 22367297
[TBL] [Abstract][Full Text] [Related]
7. Combined BRAF(V600E)-positive melanocytic lesions with large epithelioid cells lacking BAP1 expression and conventional nevomelanocytes.
Busam KJ; Sung J; Wiesner T; von Deimling A; Jungbluth A
Am J Surg Pathol; 2013 Feb; 37(2):193-9. PubMed ID: 23026932
[TBL] [Abstract][Full Text] [Related]
8. Histopathology of melanocytic lesions in a family with an inherited BAP1 mutation.
O'Shea SJ; Mitra A; Graham JL; Charlton R; Adlard J; Merchant W; Newton-Bishop JA
J Cutan Pathol; 2016 Mar; 43(3):287-9. PubMed ID: 26458093
[No Abstract] [Full Text] [Related]
9. BAP1-inactivated melanocytic tumor with preserved BAP1 expression? Morphology to the rescue!
Duncan LM; Tetzlaff MT
J Cutan Pathol; 2020 May; 47(5):459-461. PubMed ID: 32096236
[TBL] [Abstract][Full Text] [Related]
10. Intrinsic apoptosis shapes the tumor spectrum linked to inactivation of the deubiquitinase BAP1.
He M; Chaurushiya MS; Webster JD; Kummerfeld S; Reja R; Chaudhuri S; Chen YJ; Modrusan Z; Haley B; Dugger DL; Eastham-Anderson J; Lau S; Dey A; Caothien R; Roose-Girma M; Newton K; Dixit VM
Science; 2019 Apr; 364(6437):283-285. PubMed ID: 31000662
[TBL] [Abstract][Full Text] [Related]
11. Gene of the month: BAP1.
Wang A; Papneja A; Hyrcza M; Al-Habeeb A; Ghazarian D
J Clin Pathol; 2016 Sep; 69(9):750-3. PubMed ID: 27235536
[TBL] [Abstract][Full Text] [Related]
12. Melanocytic nevus-like hyperplasia and melanoma in transgenic BRAFV600E mice.
Goel VK; Ibrahim N; Jiang G; Singhal M; Fee S; Flotte T; Westmoreland S; Haluska FS; Hinds PW; Haluska FG
Oncogene; 2009 Jun; 28(23):2289-98. PubMed ID: 19398955
[TBL] [Abstract][Full Text] [Related]
13. BAP1 deficiency causes loss of melanocytic cell identity in uveal melanoma.
Matatall KA; Agapova OA; Onken MD; Worley LA; Bowcock AM; Harbour JW
BMC Cancer; 2013 Aug; 13():371. PubMed ID: 23915344
[TBL] [Abstract][Full Text] [Related]
14. Functional Link between BRCA1 and BAP1 through Histone H2A, Heterochromatin and DNA Damage Response.
Fukuda T; Tsuruga T; Kuroda T; Nishikawa H; Ohta T
Curr Cancer Drug Targets; 2016; 16(2):101-9. PubMed ID: 26517537
[TBL] [Abstract][Full Text] [Related]
15. BAP1 deletion abrogates growth and metastasis of murine cutaneous melanoma.
Luo X; Xu Y; Li Y; Zhang G; Huang S; Liu X; Ren Z; Liu S; Yu L
Melanoma Res; 2021 Apr; 31(2):119-129. PubMed ID: 33347048
[TBL] [Abstract][Full Text] [Related]
16. Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53.
Viros A; Sanchez-Laorden B; Pedersen M; Furney SJ; Rae J; Hogan K; Ejiama S; Girotti MR; Cook M; Dhomen N; Marais R
Nature; 2014 Jul; 511(7510):478-482. PubMed ID: 24919155
[TBL] [Abstract][Full Text] [Related]
17. BAP1 has a survival role in cutaneous melanoma.
Kumar R; Taylor M; Miao B; Ji Z; Njauw JC; Jönsson G; Frederick DT; Tsao H
J Invest Dermatol; 2015 Apr; 135(4):1089-1097. PubMed ID: 25521456
[TBL] [Abstract][Full Text] [Related]
18. Mouse Cutaneous Melanoma Induced by Mutant BRaf Arises from Expansion and Dedifferentiation of Mature Pigmented Melanocytes.
Köhler C; Nittner D; Rambow F; Radaelli E; Stanchi F; Vandamme N; Baggiolini A; Sommer L; Berx G; van den Oord JJ; Gerhardt H; Blanpain C; Marine JC
Cell Stem Cell; 2017 Nov; 21(5):679-693.e6. PubMed ID: 29033351
[TBL] [Abstract][Full Text] [Related]
19. NRAS-mutated melanocytic BAP1-associated intradermal tumor (MBAIT): a case report.
Blokx WA; Rabold K; Bovenschen HJ; Ligtenberg MJ; Mensenkamp AR; van Lijnschoten G; van Zelst-Stams WA; Groenen PJ
Virchows Arch; 2015 Jan; 466(1):117-21. PubMed ID: 25342144
[TBL] [Abstract][Full Text] [Related]
20. Histomorphologic spectrum of germline-related and sporadic BAP1-inactivated melanocytic tumors.
Garfield EM; Walton KE; Quan VL; VandenBoom T; Zhang B; Kong BY; Isales MC; Panah E; Kim G; Gerami P
J Am Acad Dermatol; 2018 Sep; 79(3):525-534. PubMed ID: 29753057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]